Introduction
Liver cirrhosis is the end stage of chronic liver disease in which healthy liver tissue is progressively replaced by fibrous scar tissue and regenerative nodules. This irreversible remodeling of the liver profoundly alters its architecture, blood flow, and function. One of the most serious and life-threatening consequences of cirrhosis is portal hypertension, a condition characterized by abnormally high pressure within the portal venous system. Portal hypertension, in turn, leads to the development of esophageal varices, which are enlarged, fragile veins in the lower part of the esophagus that can rupture unexpectedly and cause catastrophic gastrointestinal bleeding.
Understanding why cirrhosis causes portal hypertension requires an appreciation of the liver's unique blood supply and the structural changes that occur during chronic liver injury. The liver receives approximately 75% of its blood from the portal vein and 25% from the hepatic artery. The portal vein collects nutrient-rich blood from the stomach, intestines, pancreas, and spleen and transports it to the liver for metabolism, detoxification, and storage. Under normal circumstances, blood flows easily through the liver sinusoids before entering the hepatic veins and returning to the heart.
In cirrhosis, however, extensive fibrosis and the formation of regenerative nodules obstruct this normal blood flow. The portal vein continues delivering blood toward the liver, but the scarred hepatic tissue creates increasing resistance. As resistance rises, portal venous pressure gradually increases. Since blood cannot easily pass through the diseased liver, it seeks alternative pathways to return to the systemic circulation. These alternative channels, known as portosystemic collateral vessels, enlarge over time, and one of the most clinically significant locations is the lower esophagus.
The thin-walled veins in the distal esophagus are not designed to withstand sustained high pressure. Continuous exposure to elevated portal pressure causes these veins to dilate progressively, eventually forming esophageal varices. Their walls become stretched and fragile, making them susceptible to rupture. When a varix ruptures, the patient may experience sudden massive hematemesis, hypovolemic shock, and even death if prompt medical intervention is not provided.
Portal hypertension also produces many other complications beyond variceal bleeding, including splenomegaly, ascites, hepatic encephalopathy, hypersplenism, spontaneous bacterial peritonitis, hepatorenal syndrome, and systemic circulatory dysfunction. These complications collectively contribute to the high morbidity and mortality associated with advanced cirrhosis.
This article explores in detail how chronic liver injury progresses to cirrhosis, how fibrosis disrupts hepatic blood flow, why portal pressure rises, how collateral circulation develops, why esophageal varices form, and why these varices are prone to rupture.
Normal Anatomy of the Portal Venous System
To understand portal hypertension, one must first understand the normal anatomy and physiology of the portal venous circulation.
Unlike most organs that receive blood directly from the heart and return it immediately through veins, the gastrointestinal tract has a specialized vascular system called the portal circulation. This system allows nutrients absorbed from digestion to be processed by the liver before entering the systemic bloodstream.
The portal vein is formed behind the pancreas by the union of the superior mesenteric vein and the splenic vein. The inferior mesenteric vein usually joins the splenic vein before this union. Together, these vessels drain blood from nearly the entire gastrointestinal tract, including the stomach, small intestine, large intestine, pancreas, and spleen.
After entering the liver at the porta hepatis, the portal vein divides into right and left branches. These progressively branch into smaller portal venules, eventually emptying into specialized capillary channels known as hepatic sinusoids.
Hepatic sinusoids are unique vascular structures lined by fenestrated endothelial cells. Unlike ordinary capillaries, sinusoids permit extensive exchange between blood and hepatocytes. Nutrients, hormones, toxins, medications, bacteria, and metabolic waste products diffuse freely between sinusoidal blood and liver cells.
Within the sinusoids reside Kupffer cells, the liver's resident macrophages. These immune cells remove bacteria, damaged red blood cells, endotoxins, and foreign particles from portal blood before it reaches the systemic circulation.
After passing through the sinusoids, blood drains into central veins, which unite to form hepatic veins. These hepatic veins empty directly into the inferior vena cava, allowing blood to return to the right atrium of the heart.
Under normal physiological conditions, portal venous pressure ranges from approximately 5 to 10 mmHg. The hepatic venous pressure gradient (HVPG), which reflects the pressure difference between the portal vein and hepatic veins, normally remains below 5 mmHg. This low-pressure system ensures efficient blood flow through the liver while maintaining adequate hepatic perfusion.
The liver therefore functions as both a metabolic organ and a low-resistance vascular filter. Any disease that significantly increases resistance within the hepatic circulation disrupts this delicate balance and initiates portal hypertension.
Normal Blood Flow Through the Liver
Approximately 1.2 to 1.5 liters of blood flow through the liver every minute, representing nearly one-quarter of the cardiac output.
This dual blood supply is unique among organs.
The portal vein contributes approximately 75% of hepatic blood flow but supplies only about half of the liver's oxygen because portal blood has already passed through the gastrointestinal capillary beds.
The hepatic artery contributes approximately 25% of total blood flow but delivers nearly half of the liver's oxygen supply because arterial blood contains a much higher oxygen concentration.
Within the hepatic sinusoids, portal venous blood mixes with arterial blood, ensuring that hepatocytes receive adequate oxygen while simultaneously processing absorbed nutrients.
Blood then exits through central veins into hepatic veins before entering the inferior vena cava.
This continuous, low-pressure circulation allows the liver to perform several essential functions simultaneously:
- Detoxification of toxins and medications
- Storage of glycogen and vitamins
- Synthesis of plasma proteins
- Production of clotting factors
- Bile formation
- Cholesterol metabolism
- Hormone metabolism
- Immune surveillance
- Ammonia detoxification through the urea cycle
- Regulation of glucose homeostasis
The structural integrity of hepatic sinusoids is therefore essential for maintaining both normal blood flow and normal liver function.
Any disruption in sinusoidal architecture significantly impairs hepatic circulation.
What Is Liver Cirrhosis?
Liver cirrhosis is the final common pathway of many chronic liver diseases. Rather than representing a single disease, cirrhosis is the result of continuous cycles of liver injury, inflammation, hepatocyte death, and wound healing.
Repeated injury stimulates excessive deposition of collagen and extracellular matrix proteins within the liver. Over months or years, these fibrous deposits surround islands of surviving hepatocytes, forming regenerative nodules separated by dense fibrous septa.
The normal smooth architecture of the liver gradually disappears and is replaced by an irregular, scarred organ with distorted vascular channels.
Major causes of cirrhosis include:
- Chronic viral hepatitis (especially hepatitis B and hepatitis C)
- Chronic alcohol-related liver disease
- Non-alcoholic steatohepatitis (NASH)
- Autoimmune hepatitis
- Primary biliary cholangitis
- Primary sclerosing cholangitis
- Hemochromatosis
- Wilson disease
- Alpha-1 antitrypsin deficiency
- Chronic drug-induced liver injury
- Congenital metabolic disorders
- Chronic right-sided heart failure causing cardiac cirrhosis
Although the initiating diseases differ considerably, they ultimately produce similar microscopic and macroscopic changes within the liver.
These include:
- Extensive collagen deposition
- Fibrous septa
- Regenerative nodules
- Loss of normal lobular architecture
- Capillarization of hepatic sinusoids
- Compression of portal venules
- Compression of hepatic venules
- Distortion of intrahepatic vascular pathways
These structural abnormalities dramatically increase resistance to blood flow, setting the stage for portal hypertension.
How Chronic Liver Injury Progresses to Cirrhosis
Cirrhosis is not a sudden event but the final result of years or even decades of ongoing liver damage. Regardless of whether the injury is caused by chronic viral hepatitis, alcohol abuse, metabolic disorders, autoimmune diseases, or fatty liver disease, the liver responds through a highly organized wound-healing process. Initially, this response is protective, aiming to repair damaged tissue. However, when liver injury becomes persistent, the repair process becomes excessive and pathological, leading to fibrosis and ultimately cirrhosis.
The liver possesses a remarkable regenerative capacity. After minor injury, hepatocytes can divide rapidly to replace damaged cells while preserving the normal architecture of the organ. Unfortunately, repeated injury overwhelms this regenerative ability. Instead of restoring healthy tissue, the liver begins replacing injured areas with collagen-rich scar tissue.
Every episode of inflammation causes hepatocyte death through apoptosis or necrosis. Dead hepatocytes release intracellular molecules known as damage-associated molecular patterns (DAMPs), which activate immune cells within the liver. Kupffer cells, the resident macrophages of the liver, respond by releasing inflammatory cytokines including tumor necrosis factor-alpha (TNF-α), interleukin-1, interleukin-6, platelet-derived growth factor (PDGF), and transforming growth factor-beta (TGF-β).
Among these mediators, TGF-β is the most potent promoter of fibrosis. It activates hepatic stellate cells, which normally remain dormant in the space of Disse storing vitamin A. Once activated, these stellate cells undergo a dramatic transformation into myofibroblast-like cells capable of producing enormous amounts of collagen, fibronectin, laminin, hyaluronic acid, and other extracellular matrix proteins.
As collagen accumulates between hepatocytes and sinusoids, the normally delicate liver tissue becomes progressively stiff. Fibrous septa extend across hepatic lobules, connecting portal tracts to central veins and disrupting the normal vascular organization. Regenerating hepatocytes become trapped within these fibrous bands, forming rounded regenerative nodules that are characteristic of cirrhosis.
These nodules do not restore normal liver function because they lack the organized vascular architecture necessary for efficient blood flow. Instead, they compress nearby blood vessels, further increasing resistance within the liver.
Over many years, fibrosis progresses from mild portal fibrosis to bridging fibrosis and finally to established cirrhosis. During this progression, the liver becomes increasingly nodular, firm, and shrunken in many patients, although in some forms of cirrhosis the liver may initially enlarge before shrinking in advanced stages.
Importantly, fibrosis is not simply the accumulation of scar tissue. It fundamentally alters the three-dimensional structure of the liver. Portal venules become compressed, hepatic venules become narrowed, and sinusoids lose their normal fenestrations. Blood can no longer flow smoothly through the hepatic microcirculation, creating the conditions necessary for portal hypertension.
Hepatic Stellate Cells: The Central Drivers of Liver Fibrosis
Among all the cellular players involved in cirrhosis, hepatic stellate cells have the most critical role in the development of fibrosis and portal hypertension.
In a healthy liver, stellate cells are relatively inactive. They reside within the space of Disse between hepatocytes and sinusoidal endothelial cells, where they store approximately 80% of the body's vitamin A. Under normal conditions, these cells contribute to extracellular matrix maintenance without producing excessive collagen.
Chronic liver injury dramatically changes their behavior.
Signals released from injured hepatocytes, activated Kupffer cells, infiltrating inflammatory cells, and damaged endothelial cells stimulate stellate cells to activate. Once activated, they lose their vitamin A stores and acquire properties similar to smooth muscle cells and fibroblasts.
Activated stellate cells begin proliferating rapidly and migrate toward areas of liver injury. They synthesize large amounts of type I and type III collagen, elastin, proteoglycans, and glycoproteins that accumulate throughout the liver.
At the same time, these activated cells produce tissue inhibitors of metalloproteinases (TIMPs), which suppress the enzymes responsible for degrading collagen. As a result, scar tissue accumulates faster than it can be removed.
Activated stellate cells also become contractile due to the expression of alpha-smooth muscle actin. Their contraction narrows hepatic sinusoids, reducing blood flow through the liver even before severe fibrosis develops. Thus, portal hypertension has both a structural component caused by fibrosis and a dynamic component caused by active contraction of these cells.
Furthermore, activated stellate cells release additional inflammatory mediators that recruit more immune cells into the liver, creating a vicious cycle of inflammation, fibrosis, vascular remodeling, and increasing portal pressure.
The persistence of activated stellate cells explains why fibrosis continues to progress even after the original injury has partially subsided in some patients.
Distortion of the Liver's Vascular Architecture
One of the defining features of cirrhosis is the complete distortion of the liver's normal vascular network.
In the healthy liver, portal blood enters through portal venules and flows uniformly through low-resistance sinusoids toward the central veins. The sinusoidal channels are wide, flexible, and lined by specialized endothelial cells containing numerous fenestrations that facilitate exchange between blood and hepatocytes.
As cirrhosis develops, this orderly arrangement is progressively destroyed.
Fibrous septa physically divide hepatic lobules into irregular compartments. Portal venules become compressed by expanding scar tissue, while regenerative nodules distort the pathways through which blood normally travels.
Instead of moving smoothly through straight sinusoidal channels, blood encounters numerous mechanical obstacles. Some sinusoids become narrowed, while others are completely obliterated. Blood flow becomes turbulent, uneven, and increasingly resistant.
The endothelial cells lining hepatic sinusoids also undergo profound changes. Normally fenestrated sinusoidal endothelial cells lose their pores in a process known as capillarization. A basement membrane forms beneath these cells, making the sinusoids resemble ordinary capillaries rather than specialized exchange vessels.
Capillarization greatly reduces the ability of nutrients, oxygen, and metabolic products to move between blood and hepatocytes. This contributes not only to impaired liver function but also to increased vascular resistance.
New abnormal blood vessels form within fibrous tissue through angiogenesis. However, these vessels are disorganized and inefficient. Rather than improving hepatic circulation, they often bypass functional hepatocytes and further disrupt normal blood flow.
The cumulative effect of fibrosis, regenerative nodules, sinusoidal capillarization, vascular compression, and abnormal angiogenesis is a dramatic increase in resistance to portal blood flow. The portal vein continues delivering blood from the gastrointestinal tract, but the diseased liver acts like a partially blocked filter.
As resistance rises, portal venous pressure increases progressively. Initially, compensatory mechanisms maintain adequate circulation, but as cirrhosis advances these mechanisms become overwhelmed, leading to clinically significant portal hypertension and the formation of portosystemic collateral vessels that eventually produce esophageal varices.
Understanding Portal Hypertension
Portal hypertension is one of the most important consequences of liver cirrhosis and is responsible for many of its life-threatening complications. It is defined as an abnormal increase in pressure within the portal venous system due to obstruction of blood flow through the liver. In clinical practice, portal hypertension becomes significant when the hepatic venous pressure gradient (HVPG) exceeds 10 mmHg, as this is the threshold at which complications such as esophageal varices begin to develop. When the HVPG exceeds 12 mmHg, the risk of variceal rupture and life-threatening bleeding rises dramatically.
To understand portal hypertension, imagine the portal vein as a major highway carrying blood from the digestive organs to the liver. Under normal circumstances, traffic moves smoothly because the liver provides little resistance. In cirrhosis, extensive fibrosis and regenerative nodules act like multiple roadblocks. Although the amount of blood entering the liver remains relatively constant, the pathways through the liver become increasingly narrowed. As a result, blood backs up behind these obstructions, causing pressure to rise throughout the portal venous system.
Portal hypertension is therefore the result of two major mechanisms acting simultaneously.
The first is increased intrahepatic vascular resistance, which is caused by structural distortion of the liver. Fibrous septa, regenerative nodules, compressed portal venules, narrowed hepatic venules, and capillarized sinusoids all physically obstruct blood flow.
The second is increased portal venous inflow. As portal hypertension develops, blood vessels supplying the intestines undergo marked vasodilation due to excessive production of nitric oxide and other vasodilators. These dilated arteries deliver even more blood into the portal venous system. Thus, the liver faces not only increased resistance but also a greater volume of incoming blood, further elevating portal pressure.
Initially, the body attempts to compensate. Blood is redirected through small collateral veins, and vascular adaptations temporarily reduce the impact of rising pressure. However, these compensatory mechanisms eventually become insufficient. Portal pressure continues to increase, collateral vessels enlarge, and complications such as ascites, splenomegaly, hypersplenism, hepatic encephalopathy, and esophageal varices develop.
Portal hypertension is therefore not simply a localized liver problem. It becomes a systemic circulatory disorder affecting nearly every organ system.
Structural Causes of Increased Intrahepatic Resistance
The most important factor responsible for portal hypertension in cirrhosis is the dramatic increase in resistance to blood flow within the liver itself. Several structural abnormalities contribute to this resistance.
Fibrous Septa
Fibrous septa consist of dense collagen bands that bridge portal tracts and central veins. These scar tissue bands divide the liver into irregular compartments and physically compress portal venules and hepatic sinusoids. Blood attempting to pass through these fibrotic regions encounters substantial mechanical resistance.
Unlike healthy liver tissue, fibrous tissue is rigid and inelastic. It cannot expand when blood flow increases. Consequently, even small increases in portal blood flow produce disproportionately large increases in portal pressure.
Regenerative Nodules
As hepatocytes attempt to regenerate following repeated injury, they become enclosed within fibrous septa, forming regenerative nodules. Although these nodules contain living hepatocytes, they distort the normal vascular anatomy.
Large regenerative nodules compress adjacent sinusoids, portal venules, and hepatic venules. Instead of blood flowing smoothly through organized hepatic lobules, it must travel around irregular nodules that obstruct its path.
This distortion creates uneven pressure gradients throughout the liver and contributes significantly to portal hypertension.
Sinusoidal Capillarization
Healthy hepatic sinusoids possess large fenestrations that facilitate efficient blood flow and exchange of nutrients between plasma and hepatocytes.
During cirrhosis, these fenestrations disappear. Basement membrane material accumulates beneath endothelial cells, transforming sinusoids into capillary-like vessels.
This process, known as sinusoidal capillarization, decreases sinusoidal compliance and narrows the vascular lumen. Blood must now pass through narrower, less flexible channels, increasing vascular resistance.
Capillarization also reduces oxygen and nutrient exchange, contributing to hepatocyte dysfunction and further progression of liver disease.
Vascular Compression
Progressive fibrosis compresses intrahepatic branches of both the portal vein and hepatic veins.
Compression of portal venules restricts blood entering hepatic sinusoids.
Compression of hepatic venules impedes blood leaving the liver.
When both inflow and outflow pathways become narrowed, blood stagnates within the hepatic microcirculation, causing portal pressure to rise even further.
Dynamic Causes of Increased Portal Resistance
Structural abnormalities alone do not fully explain portal hypertension. Approximately one-third of the increased resistance in cirrhosis results from dynamic functional changes within the hepatic circulation.
The most important contributors include activated hepatic stellate cells, vascular smooth muscle contraction, endothelial dysfunction, and imbalance between vasoconstrictors and vasodilators.
Activated stellate cells develop contractile properties similar to smooth muscle cells. They wrap around hepatic sinusoids and constrict them, reducing their diameter. Even without additional scar tissue, this contraction significantly increases resistance to blood flow.
Endothelial dysfunction further worsens the situation. In healthy sinusoids, endothelial cells produce nitric oxide, a potent vasodilator that maintains low vascular resistance. During cirrhosis, nitric oxide production within the liver decreases, while vasoconstrictors such as endothelin-1, angiotensin II, thromboxane A₂, and norepinephrine become relatively more active.
The imbalance favors persistent constriction of intrahepatic blood vessels.
In addition, chronic inflammation stimulates continuous release of cytokines and growth factors that perpetuate stellate cell activation and vascular remodeling. As fibrosis progresses, these functional abnormalities become increasingly pronounced.
Because a substantial portion of portal hypertension results from reversible vascular constriction, medications such as non-selective beta-blockers and vasoactive agents can partially reduce portal pressure even though they cannot reverse the underlying fibrosis.
Why Blood Searches for Alternative Pathways
Blood always follows the path of least resistance. When cirrhosis makes passage through the liver increasingly difficult, the body attempts to bypass the obstruction.
Normally, only a tiny fraction of portal blood passes through embryonic vascular connections linking the portal and systemic circulations. These channels are insignificant in healthy individuals because portal pressure remains low.
As portal pressure rises, these dormant vascular connections gradually enlarge. Continuous high pressure stretches their walls, increasing their diameter and allowing progressively larger volumes of blood to bypass the liver.
This process is known as portosystemic collateral formation.
Collateral vessels develop at several anatomical sites where portal and systemic veins naturally communicate. Over time, these vessels become tortuous and dilated because they must accommodate far greater blood flow than they were originally designed to carry.
Although collateral formation partially relieves portal hypertension, it comes at a significant cost. Blood that bypasses the liver is no longer detoxified. Toxins such as ammonia, mercaptans, and inflammatory mediators enter the systemic circulation directly, contributing to hepatic encephalopathy and other systemic complications.
Furthermore, collateral vessels are structurally abnormal. Their walls are thin, fragile, and poorly supported by surrounding tissue. Continuous exposure to high pressure causes progressive dilation, making them increasingly susceptible to rupture.
Among all collateral pathways, the veins of the distal esophagus and proximal stomach are especially vulnerable because of their delicate structure and exposure to repeated mechanical trauma during swallowing. These dilated veins eventually become esophageal varices, one of the most feared complications of portal hypertension due to their high risk of sudden, massive hemorrhage.
Formation of Portosystemic Collateral Circulation
As portal hypertension becomes more severe, the body activates one of its most remarkable compensatory mechanisms—the formation and enlargement of portosystemic collateral vessels. These vessels provide alternative routes through which portal venous blood can bypass the high-resistance liver and return directly to the systemic circulation.
In healthy individuals, tiny communications between the portal and systemic venous systems already exist. These vessels are normally collapsed because portal pressure is low and blood flows preferentially through the liver. During cirrhosis, however, the rising pressure within the portal vein forces these dormant vascular channels to reopen and gradually enlarge.
The development of collateral vessels is not merely a passive process caused by elevated pressure. It also involves active angiogenesis, the formation of new blood vessels. Growth factors such as vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), and angiopoietins stimulate endothelial cell proliferation and remodeling of existing veins. Chronic inflammation associated with cirrhosis further enhances this process.
As a result, veins that were once microscopic become large, tortuous channels capable of carrying substantial amounts of blood. These collaterals help reduce portal pressure by diverting blood away from the liver. However, they also allow toxins, bacteria, inflammatory mediators, and ammonia absorbed from the intestines to bypass hepatic detoxification and enter the systemic circulation directly.
Although collateral formation is initially protective, it ultimately contributes to several serious complications. These include hepatic encephalopathy due to toxin accumulation, reduced hepatic perfusion that worsens liver dysfunction, and the formation of fragile varices prone to rupture.
Thus, collateral circulation represents a double-edged sword: it temporarily relieves excessive portal pressure but creates new life-threatening problems.
Major Sites of Portosystemic Anastomoses
Portosystemic anastomoses are anatomical locations where branches of the portal venous system communicate with veins of the systemic circulation. Under normal conditions, these connections are small and clinically insignificant. During portal hypertension, they enlarge dramatically.
Lower End of the Esophagus
The most clinically important anastomosis occurs at the gastroesophageal junction.
Here, the left gastric vein (coronary vein), a branch of the portal venous system, communicates with the esophageal veins that drain into the azygos and hemiazygos veins of the systemic circulation.
As portal pressure rises, increasing amounts of blood are forced through these esophageal veins. Because these vessels are thin-walled and located within the submucosa of the distal esophagus, they progressively dilate and become elongated, forming esophageal varices.
These varices are exposed to repeated trauma from swallowing food and fluctuations in intrathoracic pressure during coughing, vomiting, or straining. Combined with their fragile walls and high internal pressure, this makes them highly susceptible to rupture.
Among all collateral pathways, esophageal varices account for the greatest risk of fatal hemorrhage.
Gastric Region
Portal hypertension also causes enlargement of veins within the stomach, particularly around the gastric fundus.
These gastric varices are supplied mainly by the short gastric veins and posterior gastric veins.
Although gastric varices are less common than esophageal varices, they often bleed more severely because they are larger and receive blood directly from high-flow collateral vessels.
Bleeding from gastric varices is generally more difficult to control and is associated with higher mortality.
Rectum and Anal Canal
Another important site of portosystemic communication is the rectum.
The superior rectal vein belongs to the portal circulation, whereas the middle and inferior rectal veins drain into the systemic circulation.
Portal hypertension causes dilation of these venous channels, producing rectal varices.
These differ from ordinary hemorrhoids, although both may coexist. Rectal varices result specifically from portal hypertension and represent enlarged collateral veins rather than simple venous enlargement caused by increased intra-abdominal pressure.
Umbilical Region
In fetal life, the umbilical vein carries oxygenated blood from the placenta to the fetus. After birth, it normally closes and becomes the ligamentum teres.
Portal hypertension may reopen this obliterated vessel.
Blood then flows through dilated superficial abdominal wall veins radiating outward from the umbilicus.
This produces the characteristic appearance known as caput medusae, named after the snake-haired figure of Greek mythology because the enlarged veins resemble writhing serpents extending from the umbilicus.
Although caput medusae rarely causes bleeding, it is an important clinical sign of advanced portal hypertension.
Retroperitoneal Collaterals
Numerous small collateral vessels also develop within the retroperitoneum.
These veins connect branches of the portal circulation draining the intestines with retroperitoneal systemic veins.
Although they are usually asymptomatic, they contribute significantly to decompression of the portal venous system and may become enlarged enough to complicate abdominal surgery.
Why Esophageal Varices Develop
Esophageal varices are among the most feared complications of cirrhosis because they can rupture suddenly and cause massive upper gastrointestinal bleeding.
The lower one-third of the esophagus contains a rich network of submucosal veins. Under normal conditions, these veins carry only a modest volume of blood and remain small.
As portal pressure increases, blood flowing through the left gastric vein encounters increasing resistance within the cirrhotic liver. Unable to pass efficiently through the hepatic circulation, blood is diverted into the submucosal esophageal veins.
Initially, these veins undergo mild dilation. Over months and years, however, continuous exposure to elevated pressure causes progressive enlargement. The veins become elongated, tortuous, and protrude into the lumen of the esophagus.
Unlike arteries, veins possess relatively thin walls with little smooth muscle support. The submucosal veins of the esophagus are especially delicate because they were never designed to withstand sustained high pressures.
As blood flow increases, the venous wall stretches beyond its normal capacity. Collagen fibers become disorganized, smooth muscle support diminishes, and the vessel wall becomes progressively thinner.
The overlying esophageal mucosa also becomes attenuated. In some areas, only a thin layer of mucosa separates the high-pressure blood within the varix from the lumen of the esophagus.
Minor trauma from swallowing solid food, episodes of vomiting, severe coughing, increased intra-abdominal pressure, or sudden spikes in portal pressure may tear this fragile covering.
Once a tear occurs, the varix can bleed profusely because it is directly connected to the high-pressure portal venous system. Since portal blood flow is substantial, hemorrhage may be extremely rapid, leading to significant blood loss within minutes.
Classification of Esophageal Varices
Esophageal varices gradually enlarge as portal hypertension progresses. Endoscopic examination allows clinicians to classify varices according to their size and risk of bleeding.
Small Varices
Small varices appear as minimally elevated bluish veins within the distal esophagus. They usually flatten when the esophagus is distended with air during endoscopy.
Although the immediate bleeding risk is relatively low, small varices frequently enlarge over time if portal hypertension continues to worsen.
Without effective treatment of portal hypertension, many patients progress from small to large varices within a few years.
Medium Varices
Medium-sized varices occupy a larger portion of the esophageal lumen and no longer flatten completely during endoscopy.
Their walls are thinner, and the internal pressure is significantly higher than that of small varices.
Patients with medium varices generally require preventive therapy because the risk of first-time bleeding increases substantially.
Large Varices
Large varices are markedly dilated, tortuous veins that protrude prominently into the esophageal lumen.
These varices often occupy a significant portion of the esophageal circumference and are associated with the highest risk of rupture.
Endoscopists frequently observe red wale markings, cherry-red spots, and hematocystic spots on the surface of large varices. These red signs represent areas where the overlying mucosa has become extremely thin and indicate imminent risk of bleeding.
Large varices, especially those with red wale signs in patients with advanced cirrhosis, require urgent preventive treatment because spontaneous rupture can occur at any time.
